Patients' use and perception of medication information leaflets

Annals of Pharmacotherapy

Volumn 41, Issue 5, 2007, Pages 777-782

  Nathan, Joseph P ^a   Zerilli, Tina ^a   Cicero, Lorraine A ^a   Rosenberg, Jack M ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

Medication information leaflets; Patient information

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG INFORMATION; FEMALE; HEALTH SURVEY; HUMAN; MALE; OUTCOME ASSESSMENT; PERCEPTION; PHARMACY; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; COMPREHENSION; DRUG LABELING; FEMALE; HUMANS; MALE; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION; PERCEPTION;

EID: 34248573699     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H686     Document Type: Article

References (13)

1. Public Law 104-180, Aug. 6, 1996. www.talkaboutrx.org/documents/ Public_Law_104-180.pdf (accessed 2006 Dec 18).
2. Svarstad BL, Bultman DC, Mount JK, Tabak ER. Evaluation of written prescription information provided in community pharmacies: a study in eight states. J Am Pharm Assoc 2003;43:383-93. DOI 10.1331/154434503321831102
3. Svarstad BL, Mount JK, Tabak ER. Expert and consumer evaluation of patient medication leaflets provided in U.S. pharmacies. J Am Pharm Assoc 2005;45:443-51. DOI 10.1331/1544345054475586
4. Rollins BL, Sullivan DL. Evaluating consumer understanding of two patient instructions for use inserts provided by manufacturers. Drug Inf J 2005;39:43-51.
5. Ley P. Communicating with patients: improving communication, satisfaction and compliance. London: Croom Helm, 1988.
6. Vander Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. Ann Pharmacother 1991;25:1002-6.
7. Raynor DK, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J 2000;264:268-70.
8. Koo MM, Krass I, Aslani P. Consumer use of consumer medicine information. J Pharm Pract Res 2005;35:94-8.
9. US Food and Drug Administration. Center for Drug Evaluation and Research. Draft guidance: guidance of useful written medication information (CMI). www.fda.gov/cder/guidance/6520dft.htm (accessed 2005 Nov 22).
10. Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother 2003;37:259-67. DOI 10.1345/aph.1C328
11. US Food and Drug Administration. Center for Drug Evaluation and Research. National surveys of prescription medicine information received by consumers. www.fda.gov/cder/Offices/ods/y2ktable.htm#oral (accessed 2006 Dec 15).
12. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med 2006;166:1855-62. DOI 10.1001/archinte.166.17.1855
13. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc 2004;44:22-29. DOI 10.1331/154434504322713192